Hodgkin Lymphoma

Severe Fatigue Associated With Unemployment in Hodgkin Lymphoma Survivors

Severe Fatigue Associated With Unemployment in Hodgkin Lymphoma Survivors

By

Severe fatigue is associated with unemployment and financial problems in survivors of Hodgkin lymphoma, highlighting the need for clinicians to address fatigue in these patients.

Cancer-related Fatigue Common in Hodgkin Lymphoma Survivors

Cancer-related Fatigue Common in Hodgkin Lymphoma Survivors

By

There is a high incidence of severe acute and persistent cancer-related fatigue in survivors of Hodgkin lymphoma, regardless of tumor stage or treatment.

PET-CT Can Inform Decision to Omit Bleomycin in Hodgkin Lymphoma Treatment to Reduce Toxicity

PET-CT Can Inform Decision to Omit Bleomycin in Hodgkin Lymphoma Treatment to Reduce Toxicity

By

Omitting bleomycin from the treatment regimen for Hodgkin lymphoma in patients with negative findings on an interim PET scan led to a lower incidence of pulmonary toxic effects without significantly lowering treatment efficacy.

Patients With Hodgkin Lymphoma Resistant to Brentuximab Vedotin Have Poor Outcomes

Patients With Hodgkin Lymphoma Resistant to Brentuximab Vedotin Have Poor Outcomes

By

Patients with classical Hodgkin lymphoma who are resistant to the CD30-directed antibody-drug conjugate brentuximab vedotin have poor outcomes.

Early MRI Screening May Reduce Breast Cancer Mortality Among HL Survivors

Early MRI Screening May Reduce Breast Cancer Mortality Among HL Survivors

By

Early MRI-based screening may reduce breast cancer mortality among women treated with radiation therapy for Hodgkin lymphoma.

Model Demonstrates Benefits of MRI Screening for Breast Cancer in Survivors of Childhood Hodgkin Lymphoma

Model Demonstrates Benefits of MRI Screening for Breast Cancer in Survivors of Childhood Hodgkin Lymphoma

By

Female survivors of childhood Hodgkin lymphoma (HL) who received chest radiation can reduce their risk of breast cancer through early screening.

Inferior Outcomes for African Americans With Pediatric Hodgkin Lymphoma

Inferior Outcomes for African Americans With Pediatric Hodgkin Lymphoma

By

African-American pediatric patients with Hodgkin lymphoma still display a considerable survival disparity when compared to their white and Hispanic peers.

Reducing Treatment, Surveillance Barriers May Benefit Young Patients With Lymphoma

Reducing Treatment, Surveillance Barriers May Benefit Young Patients With Lymphoma

By

Identifying and reducing barriers to recommended treatment and surveillance in those at higher risk of mortality is essential.

Adolescent and Young-adult Survivors of Hodgkin Lymphoma May Not Adhere to Follow-up Recommendations

Adolescent and Young-adult Survivors of Hodgkin Lymphoma May Not Adhere to Follow-up Recommendations

By

Within the first year posttreatment, more than half of Hodgkin lymphoma survivors did not receive all recommended care. However, 96% had their recommended oncology visits and 70% had the recommended laboratory tests within the first 5 years.

Second Cancer Risk Persists for Survivors of Hodgkin Lymphoma

Second Cancer Risk Persists for Survivors of Hodgkin Lymphoma

Hodgkin lymphoma survivors have an increased risk of secondary cancer compared with the general population, even for those receiving more recent treatments.

Innovative Radiotherapy Controls Late Effects in Hodgkin Lymphoma in Pediatric and AYA Patients

Innovative Radiotherapy Controls Late Effects in Hodgkin Lymphoma in Pediatric and AYA Patients

By

Radiotherapy is the most effective single modality for local control of Hodgkin lymphoma. Involved site radiotherapy is a recent innovation intended to reduce the risk of late effects—an urgent goal, particularly for adolescent and young adult patients.

Negative PET Scan Post-ABVD: No Need for RT in Advanced Stage Classical Hodgkin Lymphoma

Negative PET Scan Post-ABVD: No Need for RT in Advanced Stage Classical Hodgkin Lymphoma

A PET-guided approach may reduce the need for additional radiotherapy in some patients with advanced classical Hodgkin lymphoma.

PET Can Guide Subsequent Treatment in Advanced Stage Hodgkin Lymphoma

PET Can Guide Subsequent Treatment in Advanced Stage Hodgkin Lymphoma

By

PET deemed safe for use after two cycles of BEACOPPesc chemotherapy for advanced stage Hodgkin lymphoma, according to a recent study.

TARC Confirmed as Biomarker of Response to PET, Brentuximab Vedotin in Hodgkin Lymphoma

TARC Confirmed as Biomarker of Response to PET, Brentuximab Vedotin in Hodgkin Lymphoma

By

TARC levels correlated with PET-normalization in certain patients with Hodgkin lymphoma treated with brentuximab vedotin, a study indicates.

PD-L1, PD-L2 Genetic Alterations Predict Outcome in Classical Hodgkin Lymphoma

PD-L1, PD-L2 Genetic Alterations Predict Outcome in Classical Hodgkin Lymphoma

By

A study has reaffirmed the importance of genetically defined PD-1 mediated immune evasion for patients with Hodgkin lymphoma.

Researchers Quantify Extent of Late Effects of Hodgkin Lymphoma Treatment

By

Researchers showed that an increased risk of cardiovascular disease is quantified at specific dose levels of radiation as well as anthracycline exposure.

Risk of Several Autoimmune Diseases Increased in Childhood Cancer Survivors

By

Childhood cancer survivors are at heightened risk of a wide range of autoimmune diseases. Diabetes and Addison's disease make up almost half of the excess cases, according to the findings.

Treatment for Hodgkin Lymphoma Increases Risk of Cardiovascular Disease in Survivors

Treatment for Hodgkin Lymphoma Increases Risk of Cardiovascular Disease in Survivors

By

Survivors of Hodgkin lymphoma have an increased risk for developing various late complications, including cardiovascular disease.

Social Deprivation and Gender Impact Incidence of Hodgkin Lymphoma

By

Living in overcrowded conditions appears to protect children and young adults against developing a subtype of Hodgkin lymphoma. The protective effect suggests that infections earlier in life may stimulate the immune system to deal with future infections and cancerous cells more efficiently.

Older Patients with Hodgkin Lymphoma Benefit from Treatment with Brentuximab Vedotin

By

Brentuximab vedotin is proven an effective and safe first course of treatment for older patients with Hodgkin lymphoma who are not candidates for chemotherapy.

PET-adapted treatment improves outcomes for patients with stage I/II Hodgkin lymphoma

By

Early FDG-PET adapted treatment improves the outcome of early FDG-PET-positive patients with stages I/II Hodgkin lymphoma, according to the results of a randomized trial.

Cancer scan could remove need for radiotherapy in cured patients

By

PET scan usage for patients with early stage Hodgkin lymphoma could potentially help them avoid unneeded radiotherapy.

Hodgkin lymphoma survivors have higher risk for cardiovascular diseases

By

Survivors of Hodgkin lymphoma seem to be at greater risk for cardiovascular events, according to recent research.

Treatment guidelines for pediatric Hodgkin lymphoma issued by the International Lymphoma Radiation Oncology Group (ILROG)

By

The International Lymphoma Radiation Oncology Group (ILROG) has issued a guideline outlining use of 3-D computed tomography (CT)-based radiation therapy planning.

Targeted drug doubles progression-free survival in Hodgkin lymphoma

By

A phase 3 trial of brentuximab vedotin (BV) showed that adults with hard-to-treat Hodgkin lymphoma given BV after stem cell transplantation survived without the disease progression for twice as long as when a placebo was administered.

Positive study data could improve standard of care for Hodgkin lymphoma

By

Patients with Hodgkin lymphoma who received brentuximab vedotin after transplantation lived longer without disease progression than patients who received only supportive care, per clinical trial data.

Risk of premature menopause after Hodgkin lymphoma treatment is mapped

By

Women treated for Hodgkin lymphoma will be able to better understand their risks of future infertility after researchers estimated their risk of premature menopause with different treatments.

Risk of diabetes elevated in Hodgkin lymphoma survivors

Risk of diabetes elevated in Hodgkin lymphoma survivors

Para-aortic radiation correlates with increased diabetes mellitus (DM) risk for Hodgkin's lymphoma (HL) survivors, according to a study.

MRI catches breast cancer early in at-risk survivors of childhood Hodgkin lymphoma

By

The largest clinical study to evaluate breast cancer screening of female survivors of childhood Hodgkin lymphoma, showed that MRI detected invasive breast tumors at very early stages, when cure rates are expected to be excellent.

Survivors of childhood Hodgkin lymphoma should be screened for breast cancer

Survivors of childhood Hodgkin lymphoma should be screened for breast cancer

Women that suffered from childhood Hodgkin lymphoma should seek magnetic resonance imaging (MRI) screening for early breast cancer detection.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs